Fogel & Partners advisor to Permira in its sale of Pharmaq

Fogel & Partners acted as advisor to Permira in it sales of Pharmaq, the world’s leading aquatic health group, to Zoetis Inc. for USD 765 million on a debt-free basis. Pharmaq is the world’s leading pharmaceutical company supplying the aquaculture industry. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry.